US5260206AExpiredUtility

Enzymes for breaking down moenomycins

59
Assignee: HOECHST AGPriority: Aug 20, 1988Filed: Sep 3, 1992Granted: Nov 9, 1993
Est. expiryAug 20, 2008(expired)· nominal 20-yr term from priority
C12R 2001/07C07C 59/125C07F 9/6552C12P 19/26C12N 1/205C07F 9/091C12N 9/16C07H 13/12C07C 59/60C12P 19/44C12P 7/42Y10S435/832
59
PatentIndex Score
10
Cited by
15
References
2
Claims

Abstract

A new Bacillus species and the appropriate enzymes obtained therefrom can be used to break down phosphoglycolipid antibiotics. The breakdown products of moenomycins display antibiotic activity or can be used as building blocks for the synthetic preparation of transglycosylas inhibitors.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. Purified Moenomycinase having the following characteristics: (i) the ability to cleave phosphoglycolipid antibiotics at the phosphoglycosidic linkage;   (ii) a pH optimum of 8.0 to 8.5;   (iii) a temperature optimum of 45° to 55° C.;   (iv) a K m  value of 4 to 10 mmolar based on moenomycin A as substrate; and   (v) a molecular weight of about 230,000±10,000 Dalton as determined by molecular sieve chromatography.   
     
     
       2. Moenomycinase as claimed in claim 1 produced by Bacillus spec. DSM 4675 and the variants and mutants thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.